Nerlynx

neratinib · Puma Biotechnology

Drug timelines are a Plus or Pro feature.

19 regulatory and trial events tracked for Nerlynx, covering 2012-05-14 to 2026-01-12. Get the full timeline:

Most recent: Clinical Trial Update: Neratinib Combined With Fulvestrant and Eribulin in the Treatment ofHR+/HER2+ Advanced Breast Cancer [Phase 2]